How approval of Johnson & Johnson’s ‘one and done’ COVID-19 vaccine could change Canada’s vaccination game – CBC

Canada set to purchase up to 38 million doses of single-dose vaccine approved Friday

Mar 05, 2021

A one-dose COVID-19 vaccine is now approved for use in Canada — and vaccine experts say the shot from Johnson & Johnson could give a major boost to countrywide vaccination efforts while offering a “real solution” to hasten the end of the pandemic.

Health Canada authorized its use and released details during a Friday morning announcement.

The vaccine, made by a subsidiary of Johnson & Johnson, is a non-replicating viral vector option and, unlike the three other vaccines previously approved for Canadian use, was tested during clinical trials as a single shot.

So far, Canada is expecting 10 million doses, with options to purchase up to 28 million more if necessary, with most of those shots set to arrive by the end of September.

Read more: https://www.cbc.ca/news/health/how-approval-of-johnson-johnson-s-one-and-done-covid-19-vaccine-could-change-canada-s-vaccination-game-1.5928528